Infliximab-Dyyb 32228-0019-01
- Manufacturer
- Celltrion, Inc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- March 1, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Infliximab-Dyyb | 120 mg/mL |
Selected Package
32228-0019-01Selected1 mL in 1 SYRINGE (32228-019-01)